I am delighted to share with you BU’s new Code of Practice for the Employment and Development of Research Staff. Research staff in this context are defined as staff with a primary responsibility to undertake research, including pre-and post-doctoral staff on fixed-term and open-ended contracts funded through limited period grants, named fellowships and sometimes institutional funds.
The code provides guidance on the University’s expectations for the recruitment, support, management and development of research staff in line with the Concordat to Support the Career Development of Researchers (2008) and the European Charter for Researchers (2005). It is relevant to research staff and their managers as well as to BU staff in general. It has been written by the University’s Research Concordat Steering Group and is one of the objectives from our action plan to further align BU’s policy and practice to the seven principles of the Concordat and to further improve the working environment for research staff at BU.
This is the first time that BU has had a code of practice specifically for research staff and the document acknowledges the valued contribution made by research staff to the research undertaken at BU. The further recognition of the value of research staff and the development of career opportunities for them are key matters on which we will continue to work.
Access information about BU’s work to embed the principles of the Concordat here: http://research.bournemouth.ac.uk/research-concordat/












BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease